# Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)

> **NCT00120653** · PHASE2 · WITHDRAWN · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Metoclopramide

## Key facts

- **NCT ID:** NCT00120653
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-07-14
- **Primary completion:** —
- **Final completion:** 2008-06-17
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120653, "Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00120653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*